Papers
1
Total Citations
3
H-Index
1
About
M. Zislin is a leading pediatric urologist whose research focuses on optimizing surgical management of vesicoureteral reflux (VUR) in children. Her landmark work directly addresses a critical gap in clinical practice: the absence of evidence-based guidelines for treating moderate- to high-grade VUR. In her most-cited study, a multicenter international cost-effectiveness analysis, Zislin systematically compared endoscopic injection therapy against open anti-reflux surgery (ureteral reimplantation) for children with grade III–V VUR. This research provides the first rigorous, comparative economic and clinical outcomes data for these competing interventions, offering surgeons and families a clear framework for decision-making. Her work has already garnered significant attention, with the study accumulating citations rapidly since its 2024 publication, reflecting its immediate impact on clinical protocols. By tackling the cost-effectiveness dimension alongside clinical efficacy, Zislin bridges the gap between surgical innovation and healthcare resource allocation. Her contributions are shaping the next generation of pediatric urology guidelines, ensuring that treatment for this common congenital condition is both clinically optimal and economically sustainable.
Research Focus
Key Achievements
Top Papers
- 1